1. Home
  2. ATHA vs BLIN Comparison

ATHA vs BLIN Comparison

Compare ATHA & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • BLIN
  • Stock Information
  • Founded
  • ATHA 2011
  • BLIN 2000
  • Country
  • ATHA United States
  • BLIN United States
  • Employees
  • ATHA N/A
  • BLIN N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • BLIN EDP Services
  • Sector
  • ATHA Health Care
  • BLIN Technology
  • Exchange
  • ATHA Nasdaq
  • BLIN Nasdaq
  • Market Cap
  • ATHA 14.8M
  • BLIN 16.5M
  • IPO Year
  • ATHA 2020
  • BLIN 2007
  • Fundamental
  • Price
  • ATHA $0.36
  • BLIN $1.35
  • Analyst Decision
  • ATHA Hold
  • BLIN Strong Buy
  • Analyst Count
  • ATHA 3
  • BLIN 1
  • Target Price
  • ATHA $0.50
  • BLIN $4.62
  • AVG Volume (30 Days)
  • ATHA 149.8K
  • BLIN 33.7K
  • Earning Date
  • ATHA 11-06-2025
  • BLIN 08-14-2025
  • Dividend Yield
  • ATHA N/A
  • BLIN N/A
  • EPS Growth
  • ATHA N/A
  • BLIN N/A
  • EPS
  • ATHA N/A
  • BLIN N/A
  • Revenue
  • ATHA N/A
  • BLIN $15,375,000.00
  • Revenue This Year
  • ATHA N/A
  • BLIN $2.85
  • Revenue Next Year
  • ATHA N/A
  • BLIN $15.92
  • P/E Ratio
  • ATHA N/A
  • BLIN N/A
  • Revenue Growth
  • ATHA N/A
  • BLIN 0.54
  • 52 Week Low
  • ATHA $0.22
  • BLIN $1.04
  • 52 Week High
  • ATHA $0.83
  • BLIN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 36.59
  • BLIN 44.74
  • Support Level
  • ATHA $0.35
  • BLIN $1.33
  • Resistance Level
  • ATHA $0.40
  • BLIN $1.40
  • Average True Range (ATR)
  • ATHA 0.02
  • BLIN 0.05
  • MACD
  • ATHA -0.00
  • BLIN 0.00
  • Stochastic Oscillator
  • ATHA 11.86
  • BLIN 21.36

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: